Wolverine Trading
PTCT icon

Wolverine Trading’s PTC Therapeutics PTCT Stock Holding History

Wolverine Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,900
Closed -$493K – 6057
2025
Q2 		$493K Buy
+9,900
New +$470K ﹤0.01% 2963
2023
Q3 		– Sell
-4,900
Closed -$202K – 4965
2023
Q2 		$202K Sell
4,900
-200
-4% -$9.79K ﹤0.01% 3517
2023
Q1 		$249K Buy
+5,100
New +$233K ﹤0.01% 3208
2020
Q4 		– Sell
-6,700
Closed -$317K – 5333
2020
Q3 		$317K Buy
6,700
+600
+10% +$29.5K ﹤0.01% 3329
2020
Q2 		$309K Sell
6,100
-2,600
-30% -$128K ﹤0.01% 3305
2020
Q1 		$370K Sell
8,700
-27,300
-76% -$1.37M ﹤0.01% 2989
2019
Q4 		$1.71M Sell
36,000
-15,700
-30% -$667K ﹤0.01% 1965
2019
Q3 		$1.79M Buy
51,700
+33,300
+181% +$1.45M 0.01% 1513
2019
Q2 		$828K Buy
18,400
+200
+1% +$7.9K ﹤0.01% 2217
2019
Q1 		$685K Buy
18,200
+1,700
+10% +$57.1K ﹤0.01% 2443
2018
Q4 		$528K Sell
16,500
-65,500
-80% -$2.36M ﹤0.01% 2581
2018
Q3 		$3.85M Buy
82,000
+40,800
+99% +$1.69M 0.01% 1150
2018
Q2 		$1.11M Hold
41,200
– – ﹤0.01% 2160
2018
Q1 		$1.11M Buy
41,200
+12,500
+44% +$317K ﹤0.01% 2160
2017
Q4 		$479K Sell
28,700
-26,900
-48% -$455K ﹤0.01% 3050
2017
Q3 		$1.11M Buy
55,600
+38,800
+231% +$760K ﹤0.01% 1815
2017
Q2 		$310K Buy
+16,800
New +$226K ﹤0.01% 2991

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's PTCT Position: Q3 2025 in Review

Wolverine Trading sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 10,836 shares — an estimated $564K sold.

Wolverine Trading first reported a position in PTCT in Q2 2017 and held it in 11 quarters. The position peaked at $871K in Q1 2019. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • Wolverine Trading reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 10,836 PTC Therapeutics shares in Q3 2025, an estimated $564K.
  • Wolverine Trading first reported a position in PTC Therapeutics in Q2 2017 and held it in 11 quarters.
  • Wolverine Trading's PTC Therapeutics position peaked at $871K in Q1 2019.
  • 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.